Cellules souche et Dérivés
Les inhibiteurs de cellules souches sont des composés qui ciblent spécifiquement les voies de signalisation et les protéines impliquées dans le maintien, la différenciation et la prolifération des cellules souches. Ces inhibiteurs sont cruciaux pour comprendre la biologie des cellules souches et pour développer des stratégies visant à manipuler les cellules souches à des fins thérapeutiques, telles que la médecine régénérative et le traitement du cancer. En contrôlant le destin des cellules souches, ces inhibiteurs peuvent aider à orienter la différenciation des cellules souches en types cellulaires spécifiques ou à prévenir une croissance cellulaire indésirable. Chez CymitQuimica, nous offrons une sélection d'inhibiteurs de cellules souches de haute qualité pour soutenir vos recherches en biologie des cellules souches, biologie du développement et médecine régénérative.
Sous-catégories appartenant à la catégorie "Cellules souche et Dérivés"
- Gamma-sécrétase(61 produits)
- Hérisson/Smoothened(49 produits)
- Voie de signalisation Hippo(7 produits)
- JAK(243 produits)
- Porc-épic(9 produits)
- ROCK(62 produits)
- STAT(98 produits)
- Cellules souches(205 produits)
- TGF-beta/Smad(59 produits)
- Wnt/beta-caténine(60 produits)
Affichez 2 plus de sous-catégories
487 produits trouvés pour "Cellules souche et Dérivés"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
AC430
CAS :AC430, a specific JAK2 inhibitor for cancer and autoimmune therapy, excels in preclinical trials with low doses. Developed by Ambit.Formule :C19H16FN5OCouleur et forme :SolidMasse moléculaire :349.36CIA-1 hcl(452087-38-6 Free base)
CAS :CIA-1 inhibits the nuclear receptor COUP-TFII, with IC50s ranging from 1.2 μM to 7.6 μM in prostate cancer cell lines.CIA-1 inhibits the growth of a variety ofFormule :C17H20ClN3O2SDegré de pureté :99.02%Couleur et forme :SolidMasse moléculaire :365.88Lorpucitinib
CAS :Lorpucitinib (JNJ-64251330) is a JAK kinase inhibitor used in the study of inflammatory and gastrointestinal diseases.Formule :C22H28N6O2Degré de pureté :99.72%Couleur et forme :SolidMasse moléculaire :408.5JAK3-IN-1
CAS :JAK3-IN-1 is an orally active, selective and potent JAK3 inhibitor for the study of immune system disorders.Formule :C26H30ClN7O2Couleur et forme :SolidMasse moléculaire :508.02TEAD-IN-2
CAS :TEAD-IN-2 is a potent and bifunctional TEAD inhibitor to induce TEAD protein degradation via the ubiquitination pathway, with anticancer potential.Formule :C16H18BrF3N2OCouleur et forme :SolidMasse moléculaire :391.231,2,3,4,5,6-Hexabromocyclohexane
CAS :Inhibits JAK2 autophosphorylation; non-cytotoxic at 100μM; 1μM reduces activity by 50%, 50μM nearly abolishes it.Formule :C6H6Br6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :557.54MS-1020
CAS :MS-1020 inhibits JAK3/STAT3, blocks active JAK3, suppresses JAK3/STAT5 signaling, and targets STAT3 in certain cells.Formule :C21H18N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :346.38Tyk2-IN-7
CAS :Tyk2-IN-7 is an inhibitor of TYK2 JH2, binds to the TYK2 JH2 domain (IC50: 0.00053 μM; Ki.app: 0.00007 μM).Formule :C18H15D3N6O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :401.46VT103
CAS :VT103, an oral TEAD1 palmitoylation inhibitor, shows promise against various cancers by disrupting YAP/TAZ-TEAD interactions.Formule :C18H17F3N4O2SDegré de pureté :99.58%Couleur et forme :SolidMasse moléculaire :410.41Ref: TM-T62077
1mg112,00€5mg268,00€10mg424,00€25mg735,00€50mg1.071,00€100mg1.549,00€200mg2.097,00€1mL*10mM (DMSO)295,00€JAK3/BTK-IN-2
CAS :JAK3/ BTk-in-2 is a potent JAK3/BTK inhibitor.
Formule :C25H32N8O2Degré de pureté :99.64% - 99.87%Couleur et forme :SolidMasse moléculaire :476.57EP009
CAS :EP009, a novel, selective, and orally active inhibitor of JAK3, induces therapeutic response in T-cell malignancies.Formule :C14H24O2Couleur et forme :SolidMasse moléculaire :224.34TyK2-IN-2
CAS :TyK2-IN-2 is a selective inhibitor of TYK2 (IC50s: 7 nM, 0.1 μM, and 0.05 μM for TYK2 JH2, IL-23, and IFNα).Formule :C16H18N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :310.35OICR-0547
CAS :OICR-0547 is an inactive derivative of OICR-9429 and is commonly used as a negative control for OICR-9429.Formule :C28H29F3N4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :542.55JAK1-IN-4
CAS :JAK1-IN-4 selectively blocks JAK1 (IC50 = 85 nM) over JAK2/JAK3 and halts STAT3 phosphorylation in NCI-H 1975 cells (IC50 = 227 nM).Formule :C26H32FN9O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :521.59TK4g
CAS :TK4g, a potent JAK inhibitor, has IC50s of 12.61 nM (JAK2) & 15.80 nM (JAK3); promising for lymphoid diseases & leukemia research.Formule :C19H19N3O4SCouleur et forme :SolidMasse moléculaire :385.44γ-Secretase modulator 4
CAS :γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.Formule :C23H19FN4O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :402.42Chromenone 1
CAS :Chromenone 1 is a potent potentiator of osteogenic bone morphogenetic protein (BMP).Formule :C18H10F3N3O2Degré de pureté :99.83% - 99.93%Couleur et forme :SolidMasse moléculaire :357.29Ref: TM-T61301
1mg52,00€5mg111,00€10mg162,00€25mg235,00€50mg330,00€100mg452,00€200mg607,00€1mL*10mM (DMSO)113,00€Aβ42-IN-2
CAS :Aβ42-IN-2 is a γ-secretase modulator. Aβ42-IN-2 has an IC 50 of 6.5 nM for Αβ 42. Aβ42-IN-2 can be used for the Alzheimer's disease research[1].Formule :C24H26N6O2Degré de pureté :98.09% - 99.87%Couleur et forme :SolidMasse moléculaire :430.5Ref: TM-T9641
1mg42,00€5mg94,00€10mg134,00€25mg215,00€50mg304,00€100mg420,00€200mg582,00€1mL*10mM (DMSO)93,00€GSK-3β inhibitor 12
CAS :GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.GSK-3βFormule :C14H13N3OSDegré de pureté :98.58%Couleur et forme :SolidMasse moléculaire :271.34tCFA15
CAS :tCFA15: A trimethylated long-chain fatty alcohol with a 15-carbon side chain; may regulate Notch signaling and neuron differentiation.Formule :C24H44O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :364.61γ-secretase modulator 2
CAS :Gamma-secretase modulator 2 selectively targets Alzheimer's by reducing Aβ(1-42), aiding in prevention and treatment.Formule :C25H22F4N6O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :514.47JAK-IN-21
CAS :JAK-IN-21 is a selective and potent JAK inhibitor that inhibits JAK1, JAK2, J2V617F and TYK2 with IC50 values of 1.73, 2.04, 109 and 62.9 nM, respectively.Formule :C19H16N8ODegré de pureté :99.87%Couleur et forme :SolidMasse moléculaire :372.38AF-2112
AF-2112, a TEAD inhibitor derived from Flufenamic acid, significantly diminishes the expression of CTGF, Cyr61, Axl, and NF2.
Formule :C21H18FNO3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :351.37JAK-IN-30
CAS :JAK-IN-30 (compound 31) is a water-soluble inhibitor of Janus kinases (JAKs), demonstrating inhibitory potency with half-maximal inhibitory concentration (IC50Formule :C19H26N8SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :398.53JAK-IN-28
CAS :JAK-IN-28 (Compound 111) is a Janus kinase (JAK) inhibitor potentially applicable in the research of cancer and inflammatory diseases [1].Formule :C20H18ClN7ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :407.86JAK-IN-18
CAS :"JAK-IN-18: potent JAK inhibitor for eye, skin, respiratory disease research (WO2018204238A1, comp 1)."Formule :C27H28F2N6O3Couleur et forme :SolidMasse moléculaire :522.55JAK-IN-11
CAS :JAK-IN-11 (R-348) is a potent and selective inhibitor of JAK, has the potential for the skin disorders treatment.Formule :C23H22FN5O4SDegré de pureté :99.75%Couleur et forme :SolidMasse moléculaire :483.52LY-411575 isomer 1
CAS :LY-411575 isomer 1 is a potent γ-secretase inhibitor. LY-411575 isomer 1 is an isomer of LY411575.Formule :C26H23F2N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :479.48JAK-IN-14
CAS :JAK-IN-14 (compound 16) is a specific JAK1 inhibitor. It prevents JAK1 phosphorylation by binding to the active site of JAK in immune, inflammation and cancer.Formule :C19H15FN4ODegré de pureté :98.27%Couleur et forme :SolidMasse moléculaire :334.35Ref: TM-T9764
1mg81,00€5mg170,00€10mg268,00€25mg555,00€50mg888,00€100mg1.414,00€200mg1.882,00€1mL*10mM (DMSO)178,00€Tyk2-IN-5
CAS :Tyk2-IN-5 is a selective and orally active inhibitor of Tyk2 JH2 (Ki: 0.086 nM for Tyk2 JH2; IC50: 25 nM for IFNα).Formule :C21H19FN8O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :434.43JAK3-IN-12
CAS :JAK3-IN-12 (compound 15k) is a potent inhibitor of JAK3 (IC50: 9.5 nM) and can be used in the study of rheumatoid arthritis.Formule :C19H19N5O4SCouleur et forme :SolidMasse moléculaire :413.45ELN318463
CAS :ELN 318463 selectively inhibits γ-secretase; EC50: 12 nM (PS1), 656 nM (PS2); 51x more selective for PS1; targets APP.Formule :C19H20BrClN2O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :471.8TEAD-IN-6
CAS :TEAD-IN-6 (Example 11-1) is a TEAD modulator that inhibits the YAP1/TAZ-TEAD interaction, and has applications in cancer research [1].Formule :C19H17F3N4O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :438.42JAK-2/3-IN-2
CAS :JAK-2/3-IN-2 (Compound 3h) is a potent JAK2 & JAK3 inhibitor with IC50s of 23.85 nM (JAK2) & 18.9 nM (JAK3).Formule :C19H19ClN2OSCouleur et forme :SolidMasse moléculaire :358.89CJJ300
CAS :CJJ300 is a TGF-β inhibitor disrupting TGF-β-TβR complex formation, with an IC50 of 5.3 μM, and halts cell migration.Formule :C30H33N3Degré de pureté :99.51%Couleur et forme :SolidMasse moléculaire :435.6Ref: TM-T62483
2mg35,00€5mg51,00€10mg90,00€25mg164,00€50mg259,00€100mg393,00€200mg552,00€1mL*10mM (DMSO)57,00€JI051
CAS :JI051 has anti-tumor effects and can interact with PHB2 to inhibit the proliferation of HEK293 cells and pancreatic cancer cells.Formule :C22H24N2O3Degré de pureté :≥98% - ≥98.0%Couleur et forme :SolidMasse moléculaire :364.44Aβ42-IN-1 free base
CAS :Aβ42-IN-1 free base (compound 1v), an orally active γ-secretase modulator with high brain exposure, effectively lowers Aβ42 levels, exhibiting an IC 50 of 0.091Formule :C29H26N4O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :462.54Peficitinib hydrochloride
CAS :Peficitinib HCl (ASP015K) is an oral JAK inhibitor with IC50s: JAK1 (3.9 nM), JAK2 (5.0 nM), JAK3 (0.7 nM), Tyk2 (4.8 nM).Formule :C18H23ClN4O2Couleur et forme :SolidMasse moléculaire :362.86BPN-15606
CAS :BPN-15606, an oral γ-secretase modulator, reduces Aβ42/Aβ40 with IC50 of 7/17 nM; promising PK/PD, lowers Aβ in rodent CNS.Formule :C23H23FN6OCouleur et forme :SolidMasse moléculaire :418.47JAK-IN-20
CAS :JAK-IN-20: potent oral JAK1,2,3 inhibitor with IC50s 7, 5, 14 nM respectively, good pharmacokinetics, anti-inflammatory in vivo.Formule :C28H30FN7O2Couleur et forme :SolidMasse moléculaire :515.58TGFβRI-IN-1
CAS :TGFβRI-IN-1 is an oral active and selective inhibitor of TGFβ receptor type I (TGFβRI) kinase(IC50 values of 2 nM and 7.6 μM for TGFβRI and TGFβRII,Formule :C20H14D3N5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :362.4Jaspamycin
CAS :Jaspamycin (7-CN-7-C-Ino) does not bind with purified human PKARIα.Formule :C12H12N4O5Couleur et forme :SolidMasse moléculaire :292.25RR-11a
CAS :RR-11a is a synthetic enzyme Legumain inhibitor.
Formule :C24H28N6O10Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :560.51RR-11a analog
CAS :RR-11a (aza-peptide) inhibits asparaginyl endopeptidase: IC50 - 4.5 nM (T. Vaginalis, I. ricinus), 31 nM (S. mansoni).Formule :C22H29N5O8Degré de pureté :98.80%Couleur et forme :SolidMasse moléculaire :491.49Ref: TM-T12770
1mg152,00€5mg364,00€10mg565,00€25mg1.044,00€50mg1.773,00€100mg2.602,00€1mL*10mM (DMSO)394,00€(Rac)-SIS3 free base
CAS :SIS3 free base is a potent and selective Smad3 phosphorylation inhibitor. SIS3 free base inhibits the myofibroblast differentiation of fibroblasts by TGF-β1.Formule :C28H27N3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :453.53TK4b
CAS :TK4b, a JAK inhibitor, targets leukemia/lymphoid diseases, with IC50s: 18.42 nM (JAK3) & 19.40 nM (JAK2).Formule :C21H22N2O2Couleur et forme :SolidMasse moléculaire :334.41γ-secretase modulator 1
CAS :gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.Formule :C24H24N4OSDegré de pureté :99.75% - 99.96%Couleur et forme :SolidMasse moléculaire :416.54ELN318463 racemate
CAS :ELN318463 racemate (ELN 318463 racemate) is the racemate of ELN318463 which is an amyloid precursor protein (APP) selective γ-secretase inhibitor.Formule :C19H20BrClN2O3SDegré de pureté :99.69%Couleur et forme :SolidMasse moléculaire :471.8Ref: TM-T11178L
1mg154,00€5mg370,00€10mg583,00€25mg858,00€50mg1.170,00€100mg1.575,00€1mL*10mM (DMSO)424,00€SD-1029
CAS :SD-1029 is a JAK2 inhibitor and a novel Stat3 activation inhibitor that inhibits Stat3 phosphorylation and JAK-STAT signaling.Formule :C25H32Br2Cl2N2O3Couleur et forme :SolidMasse moléculaire :639.25JAK-IN-10
CAS :JAK-IN-10 is a JAK inhibitor. JAK-IN-10 can be used for the research of dry eye disorders.Formule :C20H18FN5O3SDegré de pureté :99.53%Couleur et forme :SolidMasse moléculaire :427.45Ref: TM-T13571
1mg82,00€5mg167,00€10mg246,00€25mg405,00€50mg572,00€100mg772,00€500mg1.539,00€1mL*10mM (DMSO)178,00€CID-5056270
CAS :CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma
Formule :C17H13N3O3SDegré de pureté :99.6%Couleur et forme :SolidMasse moléculaire :339.37MSC-4106
CAS :MSC-4106, an oral YAP/TAZ-TEAD inhibitor, blocks TEAD1/3 auto-palmitoylation and suppresses NCI-H226 tumors.
Formule :C18H12F3N3O2Degré de pureté :99.89%Couleur et forme :SoildMasse moléculaire :359.3ABC1183
CAS :ABC1183, an oral diaminothiazole, inhibits GSK3α/β, CDK9, hinders cancer cell growth, induces G2/M arrest, and modulates phosphorylation.
Formule :C18H14N4OSDegré de pureté :98.92%Couleur et forme :SolidMasse moléculaire :334.39BIP-135
CAS :BIP-135 is a potent and selective ATP-competitive GSK-3 inhibitor.
Formule :C21H13BrN2O3Degré de pureté :99.93%Couleur et forme :SolidMasse moléculaire :421.24IHMT-MST1-58
CAS :IHMT-MST1-58 is a STE20-like protein 1 kinase (MST1) inhibitor (IC50:23 nM) with high efficiency, selectivity and oral activity.
Formule :C21H22N6O3SDegré de pureté :98.31% - 99.92%Couleur et forme :SolidMasse moléculaire :438.5JAK-STAT-IN-1
CAS :JAK-STAT-IN-1 is a specific JAK-STAT inhibitor indicated for the study of autoimmune diseases.Formule :C21H21N5O2Degré de pureté :99.59%Couleur et forme :SolidMasse moléculaire :375.42GSK-3β inhibitor 11
CAS :GSK-3β inhibitor 11 (compound 21) is a potent inhibitor of glycogen synthase kinase-3β (GSK-3β) with an inhibitory concentration (IC50) of 10.02 μM.
Formule :C20H15N3O4SDegré de pureté :97.33%Couleur et forme :SolidMasse moléculaire :393.42XL413 xHCl
CAS :BMS-863233 HCl is an ATP-competitive Cdc7 inhibitor (IC50: 3.4 nM) that is potent and selective.BMS-863233 HCl inhibited CK2 and PIM1 with IC50 values of 215
Formule :C14H12ClN3O2·xHClDegré de pureté :99.37% - 99.67%Couleur et forme :SolidMasse moléculaire :326.18LM-41
CAS :LM-41 is a TEAD binding agent with potential anticancer activity for the study of breast cancer.Formule :C19H14FNO2Degré de pureté :99.73%Couleur et forme :SolidMasse moléculaire :307.32GSK-3β inhibitor 2
CAS :GSK-3β inhibitor 2 (5-Thiazolecarboxamide,2-[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]-4-methoxy-) is a BBB-crossing and selective inhibitor of GSK-3β (IC50
Formule :C14H14N4O3SDegré de pureté :99.08%Couleur et forme :SolidMasse moléculaire :318.35Izencitinib
CAS :Izencitinib (JNJ-8398) is a JAK inhibitor with potential anti-inflammatory activity for the study of ulcerative colitis and Crohn;s disease.Formule :C22H26N8Degré de pureté :99.82%Couleur et forme :SolidMasse moléculaire :402.50Ref: TM-T35898
1mg84,00€5mg177,00€10mg281,00€25mg567,00€50mg888,00€100mg1.431,00€200mg1.963,00€1mL*10mM (DMSO)195,00€SJ000063181
CAS :SJ000063181 activates BMP signaling (EC50 ≤1μM), usable as probe in zebrafish embryos.
Formule :C14H14ClFN2O2Degré de pureté :99.94%Couleur et forme :SolidMasse moléculaire :296.72JAK1-IN-8
CAS :JAK1-IN-8, a specific inhibitor of Janus kinase 1 (JAK1, IC50<500 nM).
Formule :C22H23FN4O3SDegré de pureté :98.4%Couleur et forme :SolidMasse moléculaire :442.51Butyzamide
CAS :Butyzamide: oral Mpl activator, non-peptide, antagonizes TPO receptors, boosts hMpl, Ba/F3 cells, and enhances platelets in mice.Formule :C29H32Cl2N2O5SDegré de pureté :99.39% - 99.83%Couleur et forme :SoildMasse moléculaire :591.55Ref: TM-T67894
1mg149,00€5mg253,00€10mg371,00€25mg573,00€50mg862,00€100mg1.305,00€200mg1.755,00€1mL*10mM (DMSO)329,00€LEQ506
CAS :LEQ506 is a Smo inhibitor with IC50s of 2 nM and 4 nM for hSmo and mSmo, respectively.Formule :C25H32N6ODegré de pureté :99.76%Couleur et forme :SolidMasse moléculaire :432.56Ref: TM-T11838
1mg64,00€5mg145,00€10mg210,00€25mg338,00€50mg455,00€100mg610,00€200mg823,00€1mL*10mM (DMSO)160,00€STS-E412
CAS :STS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.Formule :C15H15ClN4O2Degré de pureté :99.01%Couleur et forme :SolidMasse moléculaire :318.76FzM1
CAS :FzM1, a negative allosteric modulator (NAM) of the Frizzled receptor FZD4, diminishes WNT5A-dependent WNT responsive element (WRE) activity (log EC50inh=−6.2)Formule :C21H16N2O2SDegré de pureté :99.37% - 99.89%Couleur et forme :SolidMasse moléculaire :360.43Ref: TM-T24076
1mg42,00€5mg64,00€10mg99,00€25mg188,00€50mg328,00€100mg528,00€500mg1.130,00€1mL*10mM (DMSO)62,00€TT-10
CAS :TT-10 (TAZ-K) activates YAP-TEAD; useful in heart disease with cardiomyocyte loss research.
Formule :C11H10FN3OS2Degré de pureté :99.29%Couleur et forme :SolidMasse moléculaire :283.35BMS-983970
CAS :BMS-983970 is an oral inhibitor of pan-Notch, and for the treatment of multiplecancers.Formule :C26H26F4N4O3Couleur et forme :SolidMasse moléculaire :518.5BMS-932481
CAS :BMS-932481 is a γ-secretase modulator.Formule :C24H24FN7OCouleur et forme :SolidMasse moléculaire :445.49Lepzacitinib
CAS :Lepzacitinib is a selective, inflammatory, small molecule JAK1/3(Janus kinase) inhibitor primarily used for the treatment of atopic dermatitis.Formule :C18H21N5O3Degré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :355.39Ref: TM-T78207
1mg50,00€5mg104,00€10mg167,00€25mg340,00€50mg505,00€100mg712,00€200mg1.009,00€1mL*10mM (DMSO)114,00€ROCK2-IN-6 hydrochloride
CAS :ROCK2-IN-6 hydrochloride (Comp A)为一种选择性ROCK2抑制剂，适用于研究ROCK介导的疾病、自身免疫性病症与炎症。Formule :C26H22ClF2N7ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :521.95QL-1200186
CAS :QL-1200186 is an orally active, selective TYK2 inhibitor that, upon dose-dependent oral administration, suppresses interferon-γ (IFNγ) production followingFormule :C26H27N7O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :485.54TGFβ-IN-5
CAS :TGFβ-IN-5 (WAY-641966) is a potent TGFβ inhibitor with anti-prion activity for the study of fibroproliferative diseases associated with TGF-β signaling.Formule :C20H16N4Degré de pureté :99.29% - 99.62%Couleur et forme :SolidMasse moléculaire :312.37ML115
CAS :ML115 is a potent and selective activator of transcription 3 (STAT3), with abn EC50 of 2.0 nM, and is inactive against the related STAT1 and NFκB anti-targets.Formule :C15H15ClN2O4Degré de pureté :99.97%Couleur et forme :SolidMasse moléculaire :322.74Ref: TM-T35544
1mg95,00€5mg227,00€10mg359,00€25mg630,00€50mg882,00€100mg1.188,00€200mg1.596,00€500mg2.357,00€1mL*10mM (DMSO)251,00€JAK-IN-25
CAS :JAK-IN-25 (compound 19), a potent JAK inhibitor, exhibits IC50 values of 6 nM for TYK2, 21 nM for JAK1, 8 nM for JAK2, and 1051 nM for JAK3.Formule :C19H17N5O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :379.37BRD5648
CAS :BRD5648 ((R)-BRD0705) is an inactive (R)-enantiomer of BRD0705.Formule :C20H23N3ODegré de pureté :99.89%Couleur et forme :SolidMasse moléculaire :321.42JAK-IN-4
CAS :JAK-IN-4 is a prodrug of a JAK inhibitor, effective in murine collagen induced arthritis model.Formule :C18H21N4Na2O6PDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :466.341JAK-IN-5
CAS :JAK-IN-5 is a JAK inhibitor.Formule :C27H31FN6ODegré de pureté :98.1% - 99.37%Couleur et forme :SolidMasse moléculaire :474.57Ref: TM-T11710
1mg177,00€5mg370,00€10mg552,00€25mg879,00€50mg1.189,00€100mg1.603,00€500mg3.205,00€1mL*10mM (DMSO)537,00€Ginsenoside Rk1
CAS :Ginsenoside Rk1 is a component created by processing the ginseng plant at high temperatures.Formule :C42H70O12Degré de pureté :98.46% - 99.13%Couleur et forme :SolidMasse moléculaire :767.00Myristoyl tetrapeptide-12
CAS :Myristoyl Tetrapeptide-12 activates SMAD2 and facilitates the association of SMAD3 with DNA, promoting eyelash hair growth [1] [2].Formule :C32H63N7O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :625.89Stafib-2
CAS :Stafib-2 is a potent and selective inhibitor of the transcription factor STAT5b.Stafib-2 inhibits STAT5b and STAT5a with IC50 values of 82 nM and 1.7 μM,
Formule :C28H26N2O12P2Degré de pureté :98.48%Couleur et forme :SolidMasse moléculaire :644.46Tubulin/JAK2-IN-1
CAS :Tubulin/JAK2-IN-1 (compound 7g) serves as a potent dual inhibitor targeting both Janus kinase 2 (JAK2) and microtubules, demonstrating significantFormule :C22H20N6O3Couleur et forme :SolidMasse moléculaire :416.43SWTX-143
CAS :SWTX-143, a novel covalent inhibitor, specifically and irreversibly binds to the palmitoylation pocket of all four TEAD isoforms, inhibiting the transcriptionalFormule :C19H18F3N3ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :361.36JAK-IN-1
CAS :JAK-IN-1 shows improved selectivity for JAK3 over JAK1. JAK-IN-1 is a JAK1/2/3 inhibitor with IC50s of 0.26, 0.8 and 3.2 nM, respectively.Formule :C20H24N6O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :380.44ABBV-712
CAS :ABBV-712 is a selective Tyrosine Kinase 2 (TYK2) inhibitor, demonstrating an IC50 value of 0.195 μM, and is implicated in the regulation of autoimmune diseasesFormule :C24H28N4O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :452.5TP0427736
CAS :TP0427736: ALK5 inhibitor, IC50=2.72 nM, 300x > ALK3 selectivity; counters TGF-β in human cells, extends anagen in mice.Formule :C14H10N4S2Degré de pureté :97.26%Couleur et forme :SolidMasse moléculaire :298.39YAP-TEAD-IN-2
CAS :YAP-TEAD-IN-2 (compound 6) serves as a potent inhibitor of the YAP-TEAD protein-protein interaction (PPI), demonstrating an inhibitory concentration 50 (IC50)Formule :C25H24ClFN2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :470.92DT-6
CAS :DT-6, a potent TGF-β1 inhibitor, impedes M2 macrophage-induced epithelial-to-mesenchymal transition and the invasive migration of cancer cells, thereby showing
Formule :C89H130N20O29S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2008.23JAK-IN-24
CAS :JAK-IN-24: JAK inhibitor, IC50: 0.534 nM (4 μM ATP), 24 nM (1mM ATP), STAT5 phosphorylation IC50: 86.171 nM.Formule :C20H25N5O2Couleur et forme :SolidMasse moléculaire :367.44TCJL37
CAS :TCJL37: potent, selective TYK2 inhibitor (K i 1.6 nM), oral, for IBD research.Formule :C17H11ClF2N4O2Couleur et forme :SolidMasse moléculaire :376.74JAK2-IN-4
CAS :JAK2-IN-4 is a selective JAK2/JAK3 inhibitor, with IC50 values of 0.7 nM and 23.2 nM for JAK2 and JAK3, respectively.Formule :C23H27N5O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :469.56Upadacitinib tartrate
CAS :Upadacitinib: potent, selective JAK1 inhibitor, 74x preferential to JAK2, effective in rat arthritis.Formule :C21H33F3N6O11Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :602.521NMS-P953
CAS :NMS-P953: JAK2 inhibitor, reduces tumor growth in SET-2 model, confirmed in vivo action, good pharmacokinetics and safety.Formule :C16H11ClF3N5OCouleur et forme :SolidMasse moléculaire :381.74Nezulcitinib
CAS :Nezulcitinib (TD-0903) is an inhaled pan-JAK inhibitor targeting COVID-19-related acute lung injury.Formule :C30H37N7O2Couleur et forme :SolidMasse moléculaire :527.66TM2 TEAD inhibitor
CAS :TM2 TEAD inhibitor, a robust and reversible inhibitor of the TEA domain transcription factor, presents dual inhibitory concentrations (IC50) of 38 nM for TEAD4Formule :C26H33N3O3Degré de pureté :99.91%Couleur et forme :SolidMasse moléculaire :435.57JAK kinase-IN-1
CAS :JAK kinase-IN-1 (Example 1) functions as a potent inhibitor targeting the JAK family, which includes TYK2, JAK1, JAK2, and JAK3, with IC50 values of 4.2 nM, 32Formule :C17H19F2N7OSDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :407.44JAK-IN-31
CAS :JAK-IN-31 (Example 75), a JAK inhibitor, demonstrates IC50 values of ≤0.01 µM for JAK1, ≤0.01 µM for JAK2, 0.01-0.1 µM for JAK3, and ≤0.01 µM for Tyk2,Formule :C21H19N7O2S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :465.55Tyk2-IN-9
CAS :Tyk2-IN-9: selective Tyk-2 inhibitor, IC50 of 0.076 nM (TYK2-JH2), 1.8 nM (JAK1-JH2), for inflammation/autoimmune research.Formule :C20H17N9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :383.41JAK-IN-17
"JAK-IN-17: Potent JAK inhibitor for studying ocular, skin, and respiratory diseases."Formule :C33H38F2N6O8Couleur et forme :SolidMasse moléculaire :684.69
